norfloxacin has been researched along with Rhabdomyolysis in 2 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rhabdomyolysis was detected." | 1.31 | Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. ( Cozzone, PJ; Figarella-Branger, D; Guis, S; Jouglard, J; Kozak-Ribbens, G; Pellissier, JF; Vanuxem, D, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blain, H | 1 |
| Klein, M | 1 |
| Weryha, G | 1 |
| Tréchot, P | 1 |
| Hanesse, B | 1 |
| Leclère, J | 1 |
| Guis, S | 1 |
| Jouglard, J | 1 |
| Kozak-Ribbens, G | 1 |
| Figarella-Branger, D | 1 |
| Vanuxem, D | 1 |
| Pellissier, JF | 1 |
| Cozzone, PJ | 1 |
2 other studies available for norfloxacin and Rhabdomyolysis
| Article | Year |
|---|---|
[Rhabdomyolysis and unexplained malaise. Role of combination of ciprofibrate and norfloxacin].
Topics: Anti-Infective Agents; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Humans; Hypo | 1996 |
Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment.
Topics: Adult; Anti-Infective Agents; Disease Susceptibility; Humans; Male; Malignant Hyperthermia; Muscular | 2001 |